Riding the Wave: Morgan Stanley’s Insight on Biotech Stocks Amid Fed Rate Cut (NYSE:MRK)
Riding the Wave: Morgan Stanley’s Insight on Biotech Stocks Amid Fed Rate Cut
Maksim Labkouski Morgan Stanley, known for its astute market analyses, foresees a bright future for biotech stocks as they stand on the cusp of a significant rally. The driving force behind this expected surge? None other than an anticipated Federal Reserve rate cut coupled with …